Search for Clinical Trial Results
Abdominal Neoplasms - 350 Studies Found
| Status | Study |
| Completed |
Study Name: Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer Condition:
Date: 2006-12-04 Interventions: Drug: enzastaurin hydrochloride |
| Completed |
Study Name: Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer Condition:
Date: 2005-09-26 Interventions:
|
| Completed |
Study Name: Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer Condition:
Date: 2004-09-07 Interventions:
|
| Completed |
Study Name: Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Condition:
Date: 2004-07-08 Interventions: Drug: pemetrexed disodium |
| Completed |
Study Name: Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer Condition:
Date: 2004-07-08 Interventions:
|
| Terminated |
Study Name: Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer Condition:
Date: 2004-06-10 Interventions:
|
| Terminated |
Study Name: Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer Condition:
Date: 2002-02-14 Interventions: Drug: ixabepilone |
| Terminated |
Study Name: Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer Condition:
Date: 2001-09-13 Interventions: Drug: paclitaxel |
| Completed |
Study Name: Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer Condition:
Date: 2001-09-13 Interventions: Drug: gefitinib |
| Completed |
Study Name: Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer Condition:
Date: 2001-07-11 Interventions:
|